Atlas Trials

A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2)

Clinical trial NCT03933202 · COMPLETED

Trial details

NCT number
NCT03933202
Sponsor
EMD Serono Research & Development Institute, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Sclerosis
Start date
2019-07-22
Primary completion
2024-11-11
Enrollment
291

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.